In conclusion, T-cell screening tubes can reliably screen neoplastic T cells in AITL patients with typical immunophenotyping, such as loss of surface CD3 and loss of CD7, with a relatively high ratio. Here, CD7 is linked to angioimmunoblastic T-cell lymphoma.